Filing Details
- Accession Number:
- 0001144204-10-037193
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-07-08 13:00:00
- Reporting Period:
- 2010-05-28
- Filing Date:
- 2010-07-08
- Accepted Time:
- 2010-07-08 18:50:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1072379 | Northwest Biotherapeutics Inc | NWBO.OB | Pharmaceutical Preparations (2834) | 943306718 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1289624 | F Linda Powers | 9306 Kendale Road Potomac MD 20854 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-05-28 | 100,000 | $1.03 | 33,573,510 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-06-01 | 7,900 | $1.01 | 33,565,610 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-06-02 | 32,500 | $0.97 | 33,533,110 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-06-04 | 30,000 | $0.89 | 33,503,110 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-06-07 | 79,000 | $0.93 | 33,424,110 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-06-09 | 20,000 | $0.82 | 33,404,110 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-06-10 | 233,552 | $0.93 | 33,170,558 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-06-11 | 200,000 | $0.90 | 32,970,558 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-06-14 | 7,000 | $0.91 | 32,963,558 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-06-15 | 40,048 | $0.87 | 32,923,510 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-07-02 | 866,667 | $0.75 | 33,790,177 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Warrants | $0.00 | 32,443,013 | 32,443,013 | Indirect |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
32,443,013 | 32,443,013 | Indirect |
Footnotes
- Includes 750,000 shares of common stock received by Linda F. Powers for board service on the Issuer's Board of Directors, 2,572,710 owned by Linda F. Powers, 11,041,314 shares owned by Toucan Partners and held jointly by Linda F. Powers and her husband Robert Hemphill Jr., and 19,299,486 shares owned by Toucan Capital Fund II, in which Linda F. Powers and her husband, Robert F. Hemphill, comprise the Investment Committee which has management control.
- Ms. Powers purchased 866,667 shares of the Company's common stock and warrants to purchase an additional 86,667 shares of Common Stock for a purchase price of $650,000 on the same terms and conditions as other subscribers of the Company's securities during the second quarter of 2010 ($0.75 per share and 10% warrant coverage). The warrants have an exercise price of $0.75 per share of Common Stock and an exercise period of three (3) years
- Not applicable: no derivative securities were converted or exercised.
- Includes warrants for 86,667 shares of common stock owned by Linda F. Powers, warrants for 10,321,257 shares of common stock owned by Toucan Partners and held jointly by Linda F. Powers and her husband Robert F. Hemphill, and warrants for 22,035,089 shares of common stock owned by Toucan Capital, in which Ms. Powers and Mr. Hemphill comprise the Investment Committee which has management control.
- 86,667 warrants are held directly. 32,356,346 warrants are held indirectly.